SM

Suresh Mandhana

Active Director Director DIN 06615411
DIN 06615411 First appointment Feb 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Feb 2014
Shareholding value •••• Premium profile

About Suresh Mandhana

Data last updated:

Suresh Mandhana is a Director at A-Mark Pharma Private Limited (since 2022), Director at Chemserves Pharma Private Limited (since 2017) and Additional Director at Relichem Pharma Private Limited (since 2015). The companies operate in Pharma and Consumer Goods. The 3 current companies with reported revenue have a combined latest revenue of ₹5.85 Cr; the largest is A-Mark Pharma Private Limited at ₹5.25 Cr (FY 2025). Earlier, Suresh Mandhana was a Director at Waxsen Lifescience Private Limited (from 2014).

DIN 06615411
Primary Designation Director
Industry Pharma
First Appointment 17 Feb 2014
Oldest Company Age 17 yrs
Largest company A-Mark Pharma Private Limited · ₹5.25 Cr (FY 2025)
Combined revenue ₹5.85 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
A-Mark Pharma Private Limited U24233MH2011PTC213660
Director25 Jan 20222011₹5.25 Cr (FY 2025)Active
Chemserves Pharma Private Limited U24100MH2009PTC191943
Director16 Feb 20172009₹59.7 Lakh (FY 2019)Active
Relichem Pharma Private Limited U74120MH2012PTC235716
Additional Director27 Feb 20152012₹13,846 (FY 2019)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Waxsen Lifescience Private Limited U24297MH2009PTC197046
Director17 Feb 20142009₹8.64 Cr (FY 2019)Under Cirp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chemserves Pharma Private Limited
Waxsen Lifescience Private Limited
Relichem Pharma Private Limited
A-Mark Pharma Private Limited
Premium access

Shareholding and investment profile for Suresh Mandhana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Mandhana

Suresh Mandhana currently holds 3 directorships: A-Mark Pharma Private Limited (Director, since 25 Jan 2022, revenue ₹5.25 Cr (FY 2025)); Chemserves Pharma Private Limited (Director, since 16 Feb 2017, revenue ₹59.7 Lakh (FY 2019)); Relichem Pharma Private Limited (Additional Director, since 27 Feb 2015, revenue ₹13,846 (FY 2019)).

Suresh Mandhana was first appointed on 17 Feb 2014 as Director at Waxsen Lifescience Private Limited. The most recent appointment on record is 25 Jan 2022 at A-Mark Pharma Private Limited.

The 3 current companies of Suresh Mandhana that report revenue have a combined latest revenue of ₹5.85 Cr: A-Mark Pharma Private Limited ₹5.25 Cr (FY 2025); Chemserves Pharma Private Limited ₹59.7 Lakh (FY 2019); Relichem Pharma Private Limited ₹13,846 (FY 2019).

Suresh Mandhana held 1 earlier board appointment: Waxsen Lifescience Private Limited (Director, from 17 Feb 2014).

The current boards of Suresh Mandhana's companies include Shilpi Mandhana (A-Mark Pharma Private Limited), Rajendrakumar Satyanarayan Holani (Chemserves Pharma Private Limited), Rohitash Kailashchand Mandhana (Chemserves Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available